Skip to content

Improving the Treatment of Acute Uncomplicated Diverticulitis in Routine Care

From Guidelines to Real-world Practice: a Pragmatic Before and After Study on the Treatment of Acute Uncomplicated Diverticulitis (AUD) Based on a Risk Factor Driven Treatment Algorithm (AUD Management Algorithm Protocol)

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07824180
Acronym
AUD
Enrollment
800
Registered
2026-09-17
Start date
2026-10-01
Completion date
2027-07-01
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diverticulitis

Brief summary

Acute uncomplicated diverticulitis is often treated with antibiotics, although current evidence shows that antibiotics are not always necessary. This study will evaluate whether a more standardized approach to treatment can reduce unnecessary antibiotic use without increasing the risk of treatment failure. The study will compare patients treated before and after the new treatment approach is introduced in participating Swiss hospitals. Information on treatment, hospital admissions, complications and recurrence of diverticulitis will be collected. Patients will be followed for up to 24 months.

Interventions

OTHERstandardized treatment algorithm

A standardized treatment approach based on clinical findings, laboratory results, comorbidities, immunosuppression status, and CT findings is introduced to support treatment decisions in patients with acute uncomplicated diverticulitis. Depending on these factors, patients may be managed with or without antibiotics.

Sponsors

Ente Ospedaliero Cantonale, Bellinzona
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Before-and-after study comparing a retrospective control cohort treated according to usual care with a prospective cohort treated after introduction of a standardized treatment approach. The two cohorts are enrolled in different time periods and participants are not randomized. In the prospective phase, participants are managed with or without antibiotics based on clinical, laboratory, and CT findings.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 years or older * CT-confirmirmed acute uncomplicated diverticulitis of the left colon * Ability to provide informed consent for participants in the prospective phase

Exclusion criteria

* Complicated acute diverticulitis, defined as diverticulitis with abscess, perforation (free air), fistula, or distant free fluid * Diverticulitis of the right or transverse colon -.Alternative diagnosis explaining the participant's symptoms * No possibility of completing the 90-day follow-up * Inability to provide informed consent for the prospective phase

Design outcomes

Primary

MeasureTime frameDescription
Treatment failureWithin 90 days after diagnosisTreatment failure is defined as a composite outcome including progression to complicated diverticulitis requiring percutaneous abscess drainage or surgery, delayed initiation of antibiotics after initial management without antibiotics, or unplanned hospital admission following initial outpatient treatment.

Secondary

MeasureTime frameDescription
Antibiotic useWithin 90 days after diagnosisProportion of participants receiving antibiotics
Adherence to the standardized treatment approachAt the initial treatment decisionProportion of participants whose management is consistent with the standardized treatment approach.
Outpatient versus inpatient managementAt the initial treatment decisionroportion of participants initially managed as outpatients versus inpatients.
Hospital admissionWithin 30 days after diagnosisProportion of participants readmitted to hospital.
Recurrence of diverticulitisWithin 24 months after diagnosisProportion of participants experiencing recurrence of diverticulitis.

Contacts

CONTACTDimitri Christoforidis, MD
Dimitrios.Christoforidis@eoc.ch
CONTACTElena Porro, Msc
ricerca.chirurgiaorl@eoc.ch0041918117038
PRINCIPAL_INVESTIGATORDimitri Christoforidis, MD

EOC

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026